Belong@BeiGene – Our Diversity, Equity, Inclusion, and Belonging (DEI&B) Mission Statement
At BeiGene, we like to say, ‘cancer has no borders, and neither do we.’ Because to create impactful medicines that will help everyone, we believe in including everyone.
We continually foster an environment and culture that reflects and supports the diverse communities of patients we serve, and the unique qualities that each colleague brings to BeiGene.
We don’t only want to be the best oncology company for our colleagues and our patients. We want to be the best oncology company for the world.
At BeiGene, we are driven by the power of change, and we know that if each of us focuses on diversity, equity, inclusion, and belonging at work and in our lives, we will leave a lasting legacy that will continue beyond us.
Everyone belongs at BeiGene, and we’re all in!
A Culture of Belonging
As a global organization comprised of employees at various life stages, of multiple backgrounds, and from diverse cultures, we value everyone sharing their ideas and perspectives. We know this is the foundation for greater innovation, bigger breakthroughs, and better results. We celebrate our differences and encourage colleagues to share their viewpoints to foster a culture of understanding and mutual respect. We strictly prohibit discrimination or harassment in the workplace on the grounds of race, religion, color, sex, gender identity, gender expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law.
In 2020, we formed the Inclusion, Diversity, Equity, and Awareness (IDEA) Council to provide a forum for employees to explore issues of DEI&B.
In 2021, we committed to developing a three-year global DEI&B strategy. In collaboration with the Global IDEA Council, our new strategy, Belong@BeiGene, has four focus areas—culture, career, community, and communication—and ambitious 2030 DEI&B goals, including:
- Reaching global gender parity at the VP level and above.
- Achieving a 50% improvement in workforce diversity (underrepresented groups) company-wide at management levels in the United States.
Our Commitment to Pay Equity
BeiGene is firmly committed to equal pay for equal work. As a pay-for-performance company committed to pay equity, we continue to embed policies, principles, and practices of equity and inclusion across our processes, employee life cycle, and culture. Consistent with our BeiGene promise statement to address systemic injustices and inequities, we continue to fairly compensate our employees based on the work that they perform.
BeiGene has instituted annual internal pay equity reviews. We are proud to state that our analyses have revealed no systemic pay equity issues. With a dynamic business and rapidly growing workforce, we will continue to review our processes annually going forward to ensure that all employees are paid fairly and equitably.
Our Commitment to Global Gender Parity
“
As a global company determined to deliver accessible and affordable medicines to more patients around the world, I’m committed to ensuring that health equity and diversity are central to our decision making and address the unique needs of our external stakeholders. I’m also focused on increasing workforce representation in our organization aligned with our new 2030 goal for realizing gender parity at the VP level and above.
”
–
Julius Pryor III, Global Head of Diversity & Health Equity
As a global organization, BeiGene is aligned with the UN’s Sustainable Development Goals. Specific to global gender parity, BeiGene supports the UN’s Women’s Empowerment Principles (WEP) which provides a strong framework to support companies when striving for gender equality in the workplace, marketplace, and community.
In 2022, BeiGene maintained gender parity in all levels of the organization below Vice President. At the Vice President and above level, we saw the opportunity to increase representation for women in these senior leadership positions. As a result, we established a global gender parity goal to maintain the gender parity below Vice President level and also increase the representation of women at and above Vice President level by 2030. We will be tracking our progress in this area.